| Nnabugo Darlington Ukpaka, PHARM D | |
|
712 Hunter Xing, Bossier City, LA 71111-8133 | |
| (609) 505-3534 | |
| Not Available |
| Full Name | Nnabugo Darlington Ukpaka |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 712 Hunter Xing, Bossier City, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699101659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 019975 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nnabugo Darlington Ukpaka, PHARM D 712 Hunter Xing, Bossier City, LA 71111-8133 Ph: (609) 505-3534 | Nnabugo Darlington Ukpaka, PHARM D 712 Hunter Xing, Bossier City, LA 71111-8133 Ph: (609) 505-3534 |
News Archive
Everyday, news reports detail the impact of the deficiencies in the nation's mental health care services. Even more startling, a survey from the University of Michigan reveals that many adults across the U.S. believe children and teens have extremely limited or no access to appropriate mental health care services.
Ruthigen, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company has submitted an Investigational New Drug (IND) Application to the U.S. Food and Drug Administration for its lead drug candidate RUT58-60.
Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.
BioSante Pharmaceuticals, Inc., today announced additional results from its principal LibiGel (testosterone gel) pharmacokinetic (pK) study. Top line data from this study were announced on September 12, 2011.
A new study by researchers at Columbia University Mailman School of Public Health finds that folic acid supplements can dramatically lower blood arsenic levels in individuals exposed to arsenic through contaminated drinking water.
› Verified 3 days ago
Mr. Wayne Dial, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2536 Airline Dr, Bossier City, LA 71111 Phone: 318-422-0182 | |
Colby Alexas Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2735 Beene Blvd, Bossier City, LA 71111 Phone: 318-678-6801 | |
Dr. La Tisha P. Bowie, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2107 Airline Dr, Bossier City, LA 71111 Phone: 318-742-5590 Fax: 318-742-8457 | |
Dr. Mia Ajekwu Bassaragh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3400 Airline Dr., Bossier City, LA 71111 Phone: 318-741-6589 | |
Mr. Kristopher Brent Blaylock, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 801 Benton Rd, Bossier City, LA 71111 Phone: 318-742-3509 Fax: 318-742-7730 | |
Amy Authement, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1870 Airline Dr, Bossier City, LA 71112 Phone: 318-746-8401 Fax: 318-746-8402 | |
Dr. Shawn Michael Manor, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4918 Barksdale Blvd, Bossier City, LA 71112 Phone: 318-549-2107 |